blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1778249

EP1778249 - PHOSPHONATE PRODRUGS OF A 2'-FLUORO-2',3'-DIDEHYDRO-2',3'-DIDEOXYADENOSINE ANALOGUE AS ANTI-HIV AGENTS [Right-click to bookmark this link]
Former [2007/18]NUCLEOSIDE PHOSPHONATE CONJUGATES AS ANTI HIV AGENTS
[2009/48]
StatusNo opposition filed within time limit
Status updated on  01.04.2011
Database last updated on 02.09.2024
Most recent event   Tooltip13.09.2013Lapse of the patent in a contracting state
Updated state(s): BG		published on 16.10.2013  [2013/42]
Applicant(s)For all designated states
GILEAD SCIENCES, INC.
333 Lakeside Drive Foster City
CA 94404 / US
[2007/18]
Inventor(s)01 / BOOJAMRA, Constantine G.
1 Worth Street
San Francisco, CA 94114 / US
02 / LIN, Kuei-Ying
1441 Ramon Dr.
Sunnyvale, CA94087-5833 / US
03 / MACKMAN, Richard L.
360 Ashton Avenue
Millbrae, CA 94030 / US
04 / MARKEVITCH, David Y.
3165 Sepulveda Blvd. 308
Los Angeles, CA 90034 / US
05 / PETRAKOVSKY, Oleg V.
1109 State Street
San Mateo, CA 94401 / US
06 / RAY, Adrian, S.
19 Pilot Circle
Redwood City, CA 94065 / US
07 / ZHANG, Lijun
4033 Middlefield Road
Palo Alto, California 94303 / US
 [2007/43]
Former [2007/30]01 / BOOJAMRA, Constantine G.
1 Worth Street
San Francisco, CA 94114 / US
02 / LIN, Kuei-Ying
1441 Ramon Dr.
Sunnyvale, CA94087-5833 / US
03 / MACKMAN, Richard L.
360 Ashton Avenue
Millbrae, CA 94030 / US
04 / MARKEVITCH, David Y.
3165 Sepulveda Blvd. 308
Los Angeles, CA 90034 / US
05 / PETRAKOVSKY, Oleg V.
1109 State Street
San Mateo, CA 94401 / US
06 / RAY, Adrian, S.
1927 Bridgepoint Circle, J231
San Mateo, California 94404 / US
07 / ZHANG, Lijun
4033 Middlefield Road
Palo Alto, California 94303 / US
Former [2007/18]01 / BOOJAMRA, Constantine G.
1 Worth Street
San Francisco, CA 94114 / US
02 / LIN, Kuei-Ying
4774 Canvasback Common
Fremont, CA 94555 / US
03 / MACKMAN, Richard L.
360 Ashton Avenue
Millbrae, CA 94030 / US
04 / MARKEVITCH, David Y.
3165 Sepulveda Blvd. 308
Los Angeles, CA 90034 / US
05 / PETRAKOVSKY, Oleg V.
1109 State Street
San Mateo, CA 94401 / US
06 / RAY, Adrian, S.
1927 Bridgepoint Circle, J231
San Mateo, California 94404 / US
07 / ZHANG, Lijun
4033 Middlefield Road
Palo Alto, California 94303 / US
Representative(s)Reitstötter Kinzebach
Patentanwälte
Sternwartstraße 4
81679 München / DE
[N/P]
Former [2007/18]Reitstötter - Kinzebach
Patentanwälte, Sternwartstrasse 4
81679 München / DE
Application number, filing date05777315.227.07.2005
[2007/18]
WO2005US27088
Priority number, dateUS20040591811P27.07.2004         Original published format: US 591811 P
[2007/18]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006015261
Date:09.02.2006
Language:EN
[2006/06]
Type: A2 Application without search report 
No.:EP1778249
Date:02.05.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 09.02.2006 takes the place of the publication of the European patent application.
[2007/18]
Type: B1 Patent specification 
No.:EP1778249
Date:26.05.2010
Language:EN
[2010/21]
Search report(s)International search report - published on:EP16.11.2006
ClassificationIPC:C07H19/16, C07F9/44, A61K47/48, A61K31/7076, A61K31/662, A61P31/18
[2009/48]
CPC:
C07H19/16 (EP,NO,US); C07F9/38 (KR,NO); C07F9/02 (KR);
A61K31/341 (EP,KR,US); A61K31/513 (EP,US); A61K31/662 (KR,NO,US);
A61K31/675 (EP,NO,US); A61K31/683 (EP,US); A61K31/7076 (NO);
A61K45/06 (EP,NO,US); A61K47/50 (KR); A61P31/00 (EP);
A61P31/12 (EP); A61P31/14 (EP); A61P31/18 (EP,NO);
A61P31/20 (EP); A61P43/00 (EP); C07F9/40 (NO);
C07F9/44 (NO); C07F9/65616 (EP,NO,US); C07H19/00 (EP,NO,US);
C07H19/20 (EP,NO,US) (-)
C-Set:
A61K31/341, A61K2300/00 (US,EP);
A61K31/513, A61K2300/00 (US,EP);
A61K31/675, A61K2300/00 (EP,US);
A61K31/683, A61K2300/00 (US,EP)
Former IPC [2008/13]A61K31/662, C07F9/38, A61K47/48, A61P31/18
Former IPC [2007/18]A61K31/662
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/18]
Extension statesAL26.02.2007
BA26.02.2007
HR26.02.2007
MK26.02.2007
YU26.02.2007
TitleGerman:PHOSPHONAT PRODROGEN VON EINEM ANALOG DES 2'-FLUORO-2',3'-DIDEHYDRO-2',3'-DIDEOXYADENOSINS ALS ANTI-HIV MITTEL[2009/48]
English:PHOSPHONATE PRODRUGS OF A 2'-FLUORO-2',3'-DIDEHYDRO-2',3'-DIDEOXYADENOSINE ANALOGUE AS ANTI-HIV AGENTS[2009/48]
French:PRODROGUES PHOSPHONATE D'UN ANALOGUE DE LA 2'-FLUORO-2',3'-DIDÉHYDRO-2',3'-DIDÉSOXYADÉNOSINE COMME AGENTS ANTI-VIH[2009/48]
Former [2007/18]NUKLEOSID PHOSPHONAT KONJUGATE ALS ANTI HIV MITTEL
Former [2007/18]NUCLEOSIDE PHOSPHONATE CONJUGATES AS ANTI HIV AGENTS
Former [2007/18]CONJUGUES DE PHOSPHONATE NUCLEOSIDIQUE COMME AGENTS ANTI-VIH
Entry into regional phase26.02.2007National basic fee paid 
26.02.2007Designation fee(s) paid 
26.02.2007Examination fee paid 
Examination procedure26.02.2007Amendment by applicant (claims and/or description)
26.02.2007Examination requested  [2007/18]
13.03.2008Despatch of a communication from the examining division (Time limit: M06)
22.09.2008Reply to a communication from the examining division
24.03.2009Despatch of a communication from the examining division (Time limit: M04)
03.06.2009Reply to a communication from the examining division
03.11.2009Communication of intention to grant the patent
03.03.2010Fee for grant paid
03.03.2010Fee for publishing/printing paid
Opposition(s)01.03.2011No opposition filed within time limit [2011/18]
Fees paidRenewal fee
27.07.2007Renewal fee patent year 03
25.07.2008Renewal fee patent year 04
28.07.2009Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.05.2010
BE26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
TR26.05.2010
IE27.07.2010
LU27.07.2010
BG26.08.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
HU27.11.2010
[2013/42]
Former [2012/47]AT26.05.2010
BE26.05.2010
BG26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
TR26.05.2010
IE27.07.2010
LU27.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
HU27.11.2010
Former [2012/44]AT26.05.2010
BE26.05.2010
BG26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
IE27.07.2010
LU27.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
HU27.11.2010
Former [2012/42]AT26.05.2010
BE26.05.2010
BG26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
IE27.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
HU27.11.2010
Former [2012/41]AT26.05.2010
BE26.05.2010
BG26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
IE27.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/36]AT26.05.2010
BE26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
IE27.07.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/16]AT26.05.2010
BE26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/12]AT26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/08]AT26.05.2010
CY26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/07]AT26.05.2010
CY26.05.2010
DK26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Former [2011/05]AT26.05.2010
CY26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Former [2011/04]AT26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Former [2011/01]AT26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Cited inInternational search[X]WO9119721  (GLAZIER ARNOLD [US]);
 [X]WO9200988  (BODOR NICHOLAS S [US]);
 [X]WO9324510  (CENTRE NAT RECH SCIENT [FR], et al);
 [X]RU2106353  (KORPORATSIJA S EHND TI SAJENS [GB]);
 [X]RU2188203  (EKHNOLOGII VEKTOR, et al);
 [X]WO03090690  (GILEAD SCIENCES INC [US], et al);
 [X]WO03091264  (GILEAD SCIENCES INC [US], et al);
 [PX]WO2004096233  (GILEAD SCIENCES INC [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.